Skip to main content
Log in

Suicidal ideation, depression, and health-related quality of life in patients with benign and malignant brain tumors: a prospective observational study in 83 patients

  • Clinical Article - Brain Tumors
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Abstract

Objective

Health-related quality of life (HRQoL) and psychosocial burden are of relevance in patients with intracranial tumors. We investigated the prevalence of suicidal ideation (SI), depression, and their association with HRQoL in patients with intra- (IA) and extraaxial (EA) tumors during the first 9 months after diagnosis.

Methods

Patients were recruited immediately following surgery, and re-evaluated after 3, 6, and 9 months (EORTC QLQ-C30/BN20, Beck Depression Inventory (BDI) and Appendix). Patients with a personal history of psychological comorbidity were excluded. Sociodemographic and clinical data were evaluated.

Results

IA patients had lower functioning scores and experienced more symptoms. Global Health Status was significantly lower at baseline (p = 0.038), but improved over time (p < 0.001). Seventeen patients (21.5 %) admitted to having had SI at least once during the study period (IA: n = 10/EA: n = 7). The highest rates were observed after 6 (IA: 18.8 %) and 9 months (EA: 10.0 %). Patients reporting SI had significantly higher BDI scores [p = 0.22 (baseline), p = 0.031 (3 months), p < 0.001 (6 months)]. After 6 months, HRQoL differed greatest between patients with and without SI. Most patients experienced good familial support (76 %).

Conclusions

Patients with intracranial tumors suffer from decreased HRQoL and SI regardless of histopathology. SI is associated with higher BDI scores, but not evident depression (BDI ≥ 18). Thus, patients should be screened specifically and regularly. Lower HRQoL and greatest prevalence of SI at 6 months may help clinicians to find the right time for careful monitoring of patients at risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376

    Article  CAS  PubMed  Google Scholar 

  2. Ahn MH, Park S, Lee HB, Ramsey CM, Na R, Kim SO, Kim JE, Yoon S, Hong JP (2015) Suicide in cancer patients within the first year of diagnosis. Psycho-Oncology 24:601–607

    Article  PubMed  Google Scholar 

  3. Akechi T, Nakano T, Akizuki N, Nakanishi T, Yoshikawa E, Okamura H, Uchitomi Y (2002) Clinical factors associated with suicidality in cancer patients. Jpn J Clin Oncol 32:506–511

    Article  PubMed  Google Scholar 

  4. Andrewes DG, Kaye A, Murphy M, Harris B, Aitken S, Parr C, Bates L (2003) Emotional and social dysfunction in patients following surgical treatment for brain tumour. J Clin Neurosci: Off J Neurosurg Soc Aust 10:428–433

    Article  Google Scholar 

  5. Anguiano L, Mayer DK, Piven ML, Rosenstein D (2012) A literature review of suicide in cancer patients. Cancer Nurs 35:E14–E26

    Article  PubMed  Google Scholar 

  6. Brinkman TM, Zhang N, Recklitis CJ, Kimberg C, Zeltzer LK, Muriel AC, Stovall M, Srivastava DK, Sklar CA, Robison LL, Krull KR (2014) Suicide ideation and associated mortality in adult survivors of childhood cancer. Cancer 120:271–277

    Article  PubMed  Google Scholar 

  7. Busch MA, Maske UE, Ryl L, Schlack R, Hapke U (2013) Prevalence of depressive symptoms and diagnosed depression among adults in Germany: results of the German health interview and examination survey for adults (DEGS1). Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 56:733–739

    Article  CAS  Google Scholar 

  8. Catt SL, Anderson JL, Critchley GR (2011) Patients’ and staff’s experiences of multidisciplinary follow-up for high-grade glioma after radical radiotherapy. Psychol Health Med 16:357–365

    Article  PubMed  Google Scholar 

  9. Chan CM, Wan Ahmad WA, Md Yusof M, Ho GF, Krupat E (2015) Effects of depression and anxiety on mortality in a mixed cancer group: a longitudinal approach using standardised diagnostic interviews. Psycho-Oncology 24:718–725

    Article  PubMed  Google Scholar 

  10. Chochinov HM (2001) Depression in cancer patients. Lancet Oncol 2:499–505

    Article  CAS  PubMed  Google Scholar 

  11. D’Angelo C, Mirijello A, Leggio L, Ferrulli A, Carotenuto V, Icolaro N, Miceli A, D’Angelo V, Gasbarrini G, Addolorato G (2008) State and trait anxiety and depression in patients with primary brain tumors before and after surgery: 1-year longitudinal study. J Neurosurg 108:281–286

    Article  PubMed  Google Scholar 

  12. Davies E, Hall S, Clarke C (2003) Two-year survival after malignant cerebral glioma: patient and relative reports of handicap, psychiatric symptoms and rehabilitation. Disabil Rehabil 25:259–266

    Article  CAS  PubMed  Google Scholar 

  13. Fang CK, Chang MC, Chen PJ, Lin CC, Chen GS, Lin J, Hsieh RK, Chang YF, Chen HW, Wu CL, Lin KC, Chiu YJ, Li YC (2014) A correlational study of suicidal ideation with psychological distress, depression, and demoralization in patients with cancer. Support Care Cancer: Off J Multinational Assoc Support Care Cancer 22:3165–3174

    Article  Google Scholar 

  14. Fayers PM AN, Bjondal K, Groenvold M, Curran D, Bottomley A, on behalf of the EORTC Quality of Life Group (2001) EORTC QLQ-C30 Scoring Manual (3rd edition)

  15. Goebel S, Kaup L, Mehdorn HM (2011) Measuring preoperative anxiety in patients with intracranial tumors: the Amsterdam preoperative anxiety and information scale. J Neurosurg Anesthesiol 23:297–303

    Article  PubMed  Google Scholar 

  16. Goebel S, Kaup L, Wiesner CD, Mehdorn HM (2013) Affective state and cognitive functioning in patients with intracranial tumors: validity of the neuropsychological baseline assessment. Psycho-Oncology 22:1319–1327

    Article  PubMed  Google Scholar 

  17. Goebel S, Mehdorn HM (2013) Development of anxiety and depression in patients with benign intracranial meningiomas: a prospective long-term study. Support Care Cancer: Off J Multinational Assoc Support Care Cancer 21:1365–1372

    Article  Google Scholar 

  18. Goebel S, Strenge H, Mehdorn HM (2012) Acute stress in patients with brain cancer during primary care. Support Care Cancer: Off J Multinational Assoc Support Care Cancer 20:1425–1434

    Article  Google Scholar 

  19. Hautzinger MBM, Worall H, Keller F (1995) Beck-Depression-Inventar (BDI). Huber, Testhandbuch

    Google Scholar 

  20. Jakola AS, Gulati M, Gulati S, Solheim O (2012) The influence of surgery on quality of life in patients with intracranial meningiomas: a prospective study. J Neuro-Oncol 110:137–144

    Article  Google Scholar 

  21. Karnofsky DA, Burchenal J (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM (ed) Evaluation of chemotherapeutic agents in cancer. Columbia University Press, New York, pp 191–205

    Google Scholar 

  22. Kim JM, Jang JE, Stewart R, Kim SY, Kim SW, Kang HJ, Shin IS, Park MH, Yoon JH, Yoon JS (2013) Determinants of suicidal ideation in patients with breast cancer. Psycho-Oncology 22:2848–2856

    Article  PubMed  Google Scholar 

  23. Litofsky NS, Farace E, Anderson F Jr, Meyers CA, Huang W, Laws ER Jr, Glioma Outcomes Project I (2004) Depression in patients with high-grade glioma: results of the Glioma Outcomes Project. Neurosurgery 54:358–366, discussion 366–357

    Article  PubMed  Google Scholar 

  24. Mainio A, Hakko H, Niemela A, Koivukangas J, Rasanen P (2011) Depression in relation to anxiety, obsessionality and phobia among neurosurgical patients with a primary brain tumor: a 1-year follow-up study. Clin Neurol Neurosurg 113:649–653

    Article  PubMed  Google Scholar 

  25. Mainio A, Hakko H, Niemela A, Tuurinkoski T, Koivukangas J, Rasanen P (2003) The effect of brain tumour laterality on anxiety levels among neurosurgical patients. J Neurol Neurosurg Psychiatry 74:1278–1282

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Mainio A, Tuunanen S, Hakko H, Niemela A, Koivukangas J, Rasanen P (2006) Decreased quality of life and depression as predictors for shorter survival among patients with low-grade gliomas: a follow-up from 1990 to 2003. Eur Arch Psychiatry Clin Neurosci 256:516–521

    Article  PubMed  Google Scholar 

  27. Maringwa J, Quinten C, King M, Ringash J, Osoba D, Coens C, Martinelli F, Reeve BB, Gotay C, Greimel E, Flechtner H, Cleeland CS, Schmucker-Von Koch J, Weis J, Van Den Bent MJ, Stupp R, Taphoorn MJ, Bottomley A, Project EP (2011) Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients. Ann Oncol: Off J Eur Soc Med Oncol/ESMO 22:2107–2112

    Article  CAS  Google Scholar 

  28. Misono S, Weiss NS, Fann JR, Redman M, Yueh B (2008) Incidence of suicide in persons with cancer. J Clin Oncol: Off J Am Soc Clin Oncol 26:4731–4738

    Article  Google Scholar 

  29. Scott NW, Aaronson NK, Bottomley A, de Graeff A, Groenvold M, Gundy C, Koller M, Petersen MA, Sprangers MAG (2008) EORTC QLQ-C30 Reference Values

  30. Organization WH (2014) Age-standardized suicide rate (per 100 000 population), 2012. last accessed 01.11.2015 http://gamapserver.who.int/gho/interactive_charts/mental_health/suicide_rates/atlas.html

  31. Osoba D, Aaronson NK, Muller M, Sneeuw K, Hsu MA, Yung WK, Brada M, Newlands E (1996) The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res: Int J Qual Life Aspects Treat Care Rehabil 5:139–150

    Article  CAS  Google Scholar 

  32. Osoba D, Brada M, Prados MD, Yung WK (2000) Effect of disease burden on health-related quality of life in patients with malignant gliomas. Neuro-Oncology 2:221–228

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Pranckeviciene A, Tamasauskas S, Deltuva VP, Bunevicius R, Tamasauskas A, Bunevicius A (2016) Suicidal ideation in patients undergoing brain tumor surgery: prevalence and risk factors. Support Care Cancer 24(7):2963–2970. doi:10.1007/s00520-016-3117-2

  34. Recklitis CJ, Lockwood RA, Rothwell MA, Diller LR (2006) Suicidal ideation and attempts in adult survivors of childhood cancer. J Clin Oncol: Off J Am Soc Clin Oncol 24:3852–3857

    Article  Google Scholar 

  35. Recklitis CJ, Zhou ES, Zwemer EK, Hu JC, Kantoff PW (2014) Suicidal ideation in prostate cancer survivors: understanding the role of physical and psychological health outcomes. Cancer 120:3393–3400

    Article  PubMed  Google Scholar 

  36. Renovanz M, Nadji-Ohl M, Hopf NJ (2011) Depression and quality of life in patients with gliomas and meningiomas – first results of a prospective observational study. Sektionstagung Neuroonkologie der Deutschen Gesellschaft für Neurochirurgie Rostock, conference paper

  37. Sagberg LM, Solheim O, Jakola AS (2016) Quality of survival the 1st year with glioblastoma: a longitudinal study of patient-reported quality of life. J Neurosurg 124:989–997

    Article  PubMed  Google Scholar 

  38. Singer S, Szalai C, Briest S, Brown A, Dietz A, Einenkel J, Jonas S, Konnopka A, Papsdorf K, Langanke D, Lobner M, Schiefke F, Stolzenburg JU, Weimann A, Wirtz H, Konig HH, Riedel-Heller S (2013) Co-morbid mental health conditions in cancer patients at working age—prevalence, risk profiles, and care uptake. Psycho-Oncology 22:2201–2297

    Article  Google Scholar 

  39. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for R, Treatment of Cancer Brain T, Radiotherapy G, National Cancer Institute of Canada Clinical Trials G (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996

    Article  CAS  PubMed  Google Scholar 

  40. Tang PL, Wang HH, Chou FH (2015) A systematic review and meta-analysis of demoralization and depression in patients with cancer. Psychosomatics 56:634–643

    Article  PubMed  Google Scholar 

  41. Tanriverdi D, Cuhadar D, Ciftci S (2014) Does the impairment of functional life increase the probability of suicide in cancer patients? Asian Pac J Cancer Prev: APJCP 15:9549–9553

    Article  PubMed  Google Scholar 

  42. Taphoorn MJ, Stupp R, Coens C, Osoba D, Kortmann R, van den Bent MJ, Mason W, Mirimanoff RO, Baumert BG, Eisenhauer E, Forsyth P, Bottomley A, European Organisation for R, Treatment of Cancer Brain Tumour G, Group ER, National Cancer Institute of Canada Clinical Trials G (2005) Health-related quality of life in patients with glioblastoma: a randomised controlled trial. Lancet Oncol 6:937–944

    Article  PubMed  Google Scholar 

  43. Tsay SL, Chang JY, Yates P, Lin KC, Liang SY (2012) Factors influencing quality of life in patients with benign primary brain tumors: prior to and following surgery. Support Care Cancer: Off J Multinational Assoc Support Care Cancer 20:57–64

    Article  Google Scholar 

  44. van der Vossen S, Schepers VP, Berkelbach van der Sprenkel JW, Visser-Meily JM, Post MW (2014) Cognitive and emotional problems in patients after cerebral meningioma surgery. J Rehabil Med 46:430–437

    Article  PubMed  Google Scholar 

  45. Vogelbaum MA, Jost S, Aghi MK, Heimberger AB, Sampson JH, Wen PY, Macdonald DR, Van den Bent MJ, Chang SM (2012) Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group. Neurosurgery 70:234–243, discussion 243–234

    Article  PubMed  Google Scholar 

  46. Vyssoki B, Gleiss A, Rockett IR, Hackl M, Leitner B, Sonneck G, Kapusta ND (2015) Suicide among 915,303 Austrian cancer patients: who is at risk? J Affect Disord 175:287–291

    Article  PubMed  Google Scholar 

  47. Wick W, Hartmann C, Engel C, Stoffels M, Felsberg J, Stockhammer F, Sabel MC, Koeppen S, Ketter R, Meyermann R, Rapp M, Meisner C, Kortmann RD, Pietsch T, Wiestler OD, Ernemann U, Bamberg M, Reifenberger G, von Deimling A, Weller M (2009) NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol: Off J Am Soc Clin Oncol 27:5874–5880

    Article  CAS  Google Scholar 

  48. Young THH, Curran D, Fayers P, Brandberg Y, Behalf of the EORTC Quality of Life Study Group (1999) Guidelines for Assessing Quality of Life in EORTC Clinical Trials. EORTC Quality of Life Group, Brussels

    Google Scholar 

  49. Yousaf U, Christensen ML, Engholm G, Storm HH (2005) Suicides among Danish cancer patients 1971–1999. Br J Cancer 92:995–1000

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

We thank Dr. Claudia Sassenrath for her supervision when planning the study design and phrasing the Appendix questions. We thank Stephan Kindel for revising and improving the quality of the presented artwork.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anne-Katrin Hickmann.

Ethics declarations

Funding

No funding was received for this research.

Conflict of interest

The author(s) declare that they have no competing interests

Ethical approval

This study was performed in accordance with national law, institutional ethical standards, and the Helsinki Declaration and its later amendments, after its approval by the local ethics committee (F-2010-030).

Informed consent

Prior to the first assessment all patients gave their written informed consent.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOC 51 kb)

ESM 2

(DOC 117 kb)

ESM 3

(DOC 111 kb)

Fig. 4

Individual change in GHS, BDI, and SI over time (IA vs. EA) – supplement. a–c GHS, BDI and SI in patients with intraaxial tumors. d–f GHS, BDI and SI in patients with extraaxial tumors (JPG 1580 kb)

Appendix: self-constructed questions

Appendix: self-constructed questions

Familial support

My family is very supportive in this special situation and helps me keep my spirits up.

  1. 0)

    True, I can always count on my family.

  2. 1)

    Rather true, most of the time.

  3. 2)

    Rather not true, I feel alone often.

  4. 3)

    False, I am alone.

Suicidal ideation

  1. 0)

    Correct, I have already thought about specific plans.

  2. 1)

    Rather true, I am occasionally thinking about it, but I have never made any plans.

  3. 2)

    Rather not true, I am sad, but I have never thought about it.

  4. 3)

    False, I never think about it.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hickmann, AK., Nadji-Ohl, M., Haug, M. et al. Suicidal ideation, depression, and health-related quality of life in patients with benign and malignant brain tumors: a prospective observational study in 83 patients. Acta Neurochir 158, 1669–1682 (2016). https://doi.org/10.1007/s00701-016-2844-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00701-016-2844-y

Keywords

Navigation